Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
•
Neurohospitalist
How do you treat checkpoint inhibitor induced myasthenia gravis?
Is recurrence treated differently?
Related Questions
How do you utilize corticosteroids in the management of CIDP?
How do you approach sequentially tapering combination therapy (i.e., IVIG, mycophenolate, rituximab) for dermatomyositis that is in remission?
How do you treat fatigue symptoms in myasthenia gravis?
Do you perform EMG and repetitive nerve stimulation in patients with ocular myasthenia gravis, particularly those who are AChR-positive, to assess for electrophysiological evidence of generalized disease?
When do you consider patients with acute stroke with large vessel occlusion with very low ASPECTS scores (less than 3) for endovascular thrombectomy?
In which clinical scenarios do you find medial and lateral plantar sensory or mixed nerve conduction studies to be valuable?
Would you recommend muscle or nerve biopsy in a patient with amyoplasia congenita?
How do you counsel patients who wish to travel to high altitudes with myasthenia gravis?
Should IVIG dosing in patients with autoimmune disease (i.e., dermatomyositis) who become pregnant continue to be based on actual weight at the time of each infusion, or should it be limited to pre-pregnancy weight?
How would one approach treating a patient with primary immunodeficiency on IVIG treatment who develops myasthenia gravis?
